Preliminary report an gemcitabine (G) - Ifosfamide (I) - Cisplatin (P) phase I/II trial in patients with advanced non small cell lung cancer (NSCLC)

被引：0
|
作者：
Bourgeois, H [1 ]
Lemerre, D [1 ]
Chicoyneau, V [1 ]
Paitry, T [1 ]
Chleze, S [1 ]
Fruge, F [1 ]
Boita, F [1 ]
Meurice, JC [1 ]
Daban, A [1 ]
机构：
[1] Reg Univ Hosp Miletrie, F-86021 Poitiers, France
来源：
EUROPEAN JOURNAL OF CANCER | 1999年 / 35卷
关键词：
D O I：
10.1016/S0959-8049(99)81462-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1042
引用
收藏
页码：S262 / S262
页数：1
相关论文
共 50 条
  • [41] Ifosfamide, vinorelbine and gemcitabine in advanced non-small cell lung cancer. A phase I study
    Recchia, F
    De Filippis, S
    Rosselli, M
    Pompili, P
    Guerriero, G
    Rea, S
    EUROPEAN JOURNAL OF CANCER, 1999, 35 (10) : 1457 - 1461
  • [42] A phase II trial of pemetrexed (P), gemcitabine (G), and bevacizumab (BV) in untreated patients (pts) with advanced non-small cell lung cancer (NSCLC)
    Wozniak, A. J.
    Kalemkerian, G. P.
    Gadgeel, S. M.
    Schneider, B. J.
    Valdivieso, M.
    Venkatramanamoorthy, R.
    Hackstock, D. M.
    Chen, W.
    Heilbrun, L. K.
    Ruckdeschel, J. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [43] A PHASE II TRIAL OF PEMETREXED (P), GEMCITABINE (G), AND BEVACIZUMAB (BV) IN UNTREATED PATIENTS (PTS) WITH ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC)
    Wozniak, Antoinette
    Kalemkerian, Gregory
    Gadgeel, Shirish M.
    Ramnath, Nithya
    Schneider, Bryan
    Valdivieso, Manuel
    Smith, Daryn
    Hackstock, Deborah
    Chen, Wei
    Ruckdeschel, John
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1234 - S1235
  • [44] Phase I II trial with cisplatin and increasing doses of gemcitabine in stage IV non-small cell lung cancer (NSCLC) diseminado.
    Martínez, J
    Artal, A
    Alonso, V
    Herrero, A
    Maurel, J
    Zorrilla, M
    Puértolas, T
    Ceballos, C
    Antón, A
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S67 - S67
  • [45] A phase II trial of pemetrexed (P), gemcitabine (G), and bevacizumab (BV) in untreated patients (pts) with advanced non-small cell lung cancer (NSCLC)
    Wozniak, Antoinette J.
    Kalemkerian, Gregory P.
    Gadgeel, Shirish M.
    Schneider, Bryan J.
    Valdivieso, Manuel
    Smith, Daryn
    Hackstock, Deborah M.
    Chen Wei
    Heilbrun, Lance K.
    Ruckdeschel, John D.
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S454 - S454
  • [46] Phase II trial of gemcitabine and cisplatin as first-line treatment of advanced non-small cell lung cancer (NSCLC).
    Lee, NS
    Byun, JH
    Bae, SB
    Kim, CK
    Lee, KT
    Park, SK
    Park, KK
    Won, JH
    Hong, DS
    Park, HS
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 701S - 701S
  • [47] Preliminary results of a phase II trial of Docetaxel (D) and Gemcitabine (G) in advanced Non-Small Cell Lung Cancer (NSCLC) in elderly and/or unfit patients (PTS)
    Buffoni, Lucio
    Grillo, Raffaella
    Barone, Carla
    Dongiovanni, Diego
    Gaspari, Fabio
    Giacobino, Alice
    Consito, Lorena
    Ciuffreda, Libero
    Schena, Marina
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S668 - S668
  • [48] Gemcitabine plus cisplatin in advanced non small cell lung cancer (NSCLC)
    Casal, J
    Huidobro, G
    Grande, C
    ANNALS OF ONCOLOGY, 1998, 9 : 103 - 103
  • [49] Gemcitabine and cisplatin for advanced non-small cell lung cancer (NSCLC)
    Casal, J
    Grande, C
    Caeiro, M
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 1083 - 1083
  • [50] A new biweekly schedule of carboplatin and gemcitabine: Phase I feasibility trial in patients with advanced non-small cell lung cancer (NSCLC).
    Mancuso, A
    Migliorino, MR
    Martelli, O
    Belli, R
    Di Molfetta, M
    De Petris, L
    Di Salvia, R
    De Marinis, F
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 677S - 677S
12345